Miller Dieker syndrome

Actionable Insights Powered by AI

Gilead’s Magrolimab Ineffective, Linked to Increased Risk of Death in MDS Patients

Gilead, Magrolimab, MDS, Myelodysplastic Syndrome, Cancer Treatment, Clinical Trials, Safety Concerns